![[News] China Makes Breakthrough in Chip Technology, Paving the Way for Lithography Advancements – TrendForce](https://earth-news.info/wp-content/uploads/2025/11/324664-news-china-makes-breakthrough-in-chip-technology-paving-the-way-for-lithography-advancements-trendforce-360x180.jpg)
GUANGZHOU, China, October 30, 2024 – Fangzhou Inc. (06086.HK), a frontrunner in internet healthcare innovation, has proudly secured a spot on the prestigious ”AI Catalyst” Enterprise Billboard during the 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference. This recognition highlights Fangzhou’s pivotal role in advancing artificial intelligence applications in online healthcare and chronic disease management. Utilizing sophisticated technologies such as AI-driven assistants and big data analytics, Fangzhou aims to improve its chronic disease management offerings while enhancing the experience for both patients and healthcare professionals.
Commenting on this achievement, CEO Mr. Xie Fangmin expressed his gratitude: “Being acknowledged as an innovator in AI technology is incredibly rewarding for us. This tribute underscores our commitment to leveraging technology to transform healthcare delivery while ensuring high-quality service for patients and providers.”
Guangdong: Leading the Charge in AI Integration
The Guangdong province is at the forefront of promoting artificial intelligence across diverse sectors. In May of this year, it unveiled initiatives titled “Measures for Empowering Various Industries with Artificial Intelligence,” aiming to establish over 500 application scenarios powered by AI within key industries like manufacturing, education, and senior support services. Following this framework was October’s release of the “Action Plan for Promoting High-Quality Development within Guangdong’s Life Sciences Industry,” which presents 38 strategies focused on enhancing Guangdong’s status as a premier biotech enterprise zone.
An Overview of Fangzhou Inc.
Fangzhou Inc., recognized as China’s leading platform dedicated to online chronic disease management (stock code: 06086.HK), boasts an impressive user base of approximately 45.6 million registered patients along with around 217,000 active medical professionals connected through its services (data current as of June 30, 2024). The company specializes in providing personalized medical solutions tailored towards meeting the needs associated with chronic illnesses. To discover more about their offerings or corporate updates, please visit Fangzhou Investor Relations.
Insights from the Greater Bay Area Artificial Intelligence Industry Conference
The recent Greater Bay Area Artificial Intelligence Industry Conference took place on October 23rd at Nansha in Guangzhou City. Organized by experts under the aegis of Guangdong Province’s Department of Science and Technology and aided by organizations like Guangzhou University and various industry committees focused on smart manufacturing innovations led to fruitful discussions among over a thousand attendees including notable academicians exploring emerging trends related to AI technologies.
Disclaimer: Forward-looking statements appear within this press announcement; actual outcomes may differ significantly owing to numerous variables involved; hence readers should consider these statements cautiously when assessing future implications.
Media Contacts
If you would like further information or wish to arrange interviews,
please contact:
Xingwei Zhao, Associate Director of Public Relations Email: [email protected]
SOURCE: Fangzhou Inc.
